These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17521343)

  • 1. Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs.
    Gazzola DM; Balcer LJ; French JA
    Epilepsia; 2007 Jul; 48(7):1303-7. PubMed ID: 17521343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies?
    Zaccara G; Messori A; Cincotta M; Burchini G
    Acta Neurol Scand; 2006 Sep; 114(3):157-68. PubMed ID: 16911343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of seizure freedom in adjunctive therapy studies in refractory partial epilepsy: the levetiracetam experience.
    Leppik I; De Rue K; Edrich P; Perucca E
    Epileptic Disord; 2006 Jun; 8(2):118-30. PubMed ID: 16793573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disability.
    Simister RJ; Sander JW; Koepp MJ
    Epilepsy Behav; 2007 Mar; 10(2):336-9. PubMed ID: 17267290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective audits with newer antiepileptic drugs in focal epilepsy: insights into population responses?
    Brodie MJ; Kelly K; Stephen LJ
    Epilepsy Behav; 2014 Feb; 31():73-6. PubMed ID: 24361766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of three lamotrigine extended-release clinical trials: comparison of pragmatic ITT and LOCF methodologies.
    French JA; Hammer AE; Vuong A; Messenheimer JA
    Epilepsy Res; 2012 Aug; 101(1-2):141-7. PubMed ID: 22497754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Last-observation-carried-forward imputation method in clinical efficacy trials: review of 352 antidepressant studies.
    Woolley SB; Cardoni AA; Goethe JW
    Pharmacotherapy; 2009 Dec; 29(12):1408-16. PubMed ID: 19947800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative retention rates and long-term tolerability of new antiepileptic drugs.
    Chung S; Wang N; Hank N
    Seizure; 2007 Jun; 16(4):296-304. PubMed ID: 17267243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of antiepileptic drug withdrawal: a randomized, double-blind study (Akershus Study).
    Lossius MI; Hessen E; Mowinckel P; Stavem K; Erikssen J; Gulbrandsen P; Gjerstad L
    Epilepsia; 2008 Mar; 49(3):455-63. PubMed ID: 17888074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-sensitivity of skin rashes with antiepileptic drug use.
    Hirsch LJ; Arif H; Nahm EA; Buchsbaum R; Resor SR; Bazil CW
    Neurology; 2008 Nov; 71(19):1527-34. PubMed ID: 18981374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new look at the second-generation antiepileptic drugs: a decade of experience.
    LaRoche SM
    Neurologist; 2007 May; 13(3):133-9. PubMed ID: 17495757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Newer antiepileptic drugs].
    Matsuura M
    Brain Nerve; 2007 Feb; 59(2):147-56. PubMed ID: 17380779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zonisamide: new drug. No advantage in refractory partial epilepsy.
    Prescrire Int; 2007 Jun; 16(89):95-7. PubMed ID: 17582922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discontinuation of anticonvulsant medication after epilepsy surgery in children.
    Hoppe C; Poepel A; Sassen R; Elger CE
    Epilepsia; 2006 Mar; 47(3):580-3. PubMed ID: 16529625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epilepsy surgery, antiepileptic drug trials, and the role of evidence.
    Janszky J; Kovacs N; Gyimesi C; Fogarasi A; Doczi T; Wiebe S
    Epilepsia; 2010 Jun; 51(6):1004-9. PubMed ID: 20384716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isobolographic characterization of interactions of levetiracetam with the various antiepileptic drugs in the mouse 6 Hz psychomotor seizure model.
    Wojda E; Wlaz A; Patsalos PN; Luszczki JJ
    Epilepsy Res; 2009 Oct; 86(2-3):163-74. PubMed ID: 19596559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.